Epstein–Barr Virus‐associated Leiomyosarcoma of the Larynx in an Adult Patient with Human Immunodeficiency Virus Infection: Case Report and Review of the Literature

Jian-di Jin,Zhe Chen,Zai-Zai Cao,Shuihong Zhou,Xiuming Zhang,H. Yao

DOI: https://doi.org/10.1002/hed.27184

2022-01-01

Head and Neck

Abstract:We investigated the clinical features, treatment, and prognosis of laryngeal leiomyosarcoma (LLMS) and Epstein–Barr virus‐associated (EBV‐associated) LMS. We report a case of EBV‐associated LLMS in an adult patient with HIV infection. We also conducted a review of the English‐language literature on LLMS and EBV‐associated leiomyosarcoma. To the best of our knowledge, 62 cases of LLMS and EBV‐associated leiomyosarcoma have been reported to date. Of patients with LLS, 18.9% had distant metastases and 17.0% had local recurrence. The overall 5‐year survival rate was 64.0%. Distant metastases affected the survival of patients with LLMS (p = 0.04). EBV‐positive patients had a low survival rate (p = 0.01). Among patients with EBV‐associated LMS, 8.2% had distant metastases and recurrence and the overall 5‐year survival rate was 50.0%. EBV‐associated LLMS is rare. The EBV infection might be a poor prognostic factor of LLMS.